Doriden is a brand name for a sedative-hypnotic medication called glutethimide, which belongs to the class of drugs known as barbiturates. It was once widely prescribed to relieve anxiety and to induce sleep in individuals suffering from insomnia.
Typically, doriden is available in tablet form for oral administration. It works by depressing the central nervous system, which results in sedation, relaxation, and sleep induction. Due to its sedative properties, doriden has historically been used as a short-term treatment for insomnia, especially in cases where other non-barbiturate sedatives were found ineffective.
However, doriden has significant abuse potential and is classified as a Schedule II controlled substance due to its high risk for dependence and addiction. Prolonged use may result in physical and psychological dependence, making it crucial for individuals to use this medication strictly under the guidance and prescription of a qualified healthcare professional.
Furthermore, doriden carries the risk of various side effects, including dizziness, drowsiness, confusion, impaired motor coordination, respiratory depression, and even overdose. This medication should not be used in combination with alcohol or other central nervous system depressants, as it can intensify their effects and increase the risk of adverse reactions.
It is worth noting that the use of doriden has significantly declined over the years due to the introduction and widespread availability of safer and less addictive alternatives for treating anxiety and insomnia.
